From CARE
Panacea Biotec has received revision in credit ratings from CARE as under -1. Long Term Bank Facilities - Revised from CARE B+; Stable (Single B Plus; Outlook:Stable)to CARE D
2. Short Term Bank Facilities - Revised from CARE A4 (A Four) to CARE D
The revision in the ratings assigned to the bank facilities of the company is on account of the delays in servicing of principal instalment of the ECB loan, due to the cash flow challenges.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
